API
< Back to all clusters
[HEALTH] · Bulgaria · 6 sources

started · updated

Bulgaria faces influenza vaccine delays due to production issues

Bulgarian Health Minister Katya Ivkova has addressed delays in influenza vaccine deliveries for the 2026/2027 season. According to a written response to Parliament, the delays are primarily due to operational difficulties in the filling and packaging processes.

Additional factors contributing to the shortage include the complex process of incorporating new vaccine strains recommended by the World Health Organization and the late determination of the influenza B virus type. Other issues cited include delivery planning, regulatory requirements, and market demand.

Regarding availability, Swiss Biopharma reported the delivery of 150,000 doses to Bulgaria by October 21, including 100,000 doses of Vaxigrip and 50,000 doses of Efluelda. For the retail pharmacy market, an additional 30,000 doses are expected, bringing the total amount available for free sale to 100,000 doses.

The Ministry of Health clarified that it is not a party to the commercial negotiations between marketing authorization holders and wholesalers, and therefore lacks the authority to directly intervene in the negotiation process or mandate specific delivery timelines for the free market.

Entities

Bulgaria · Katya Ivkova · Ministry of Health · Swiss Biopharma · World Health Organization